342 related articles for article (PubMed ID: 28779849)
21. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
22. Leptomeningeal carcinomatosis: easy to miss.
Sekhar A; Corbo B; Das K; Biswas S
J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406
[TBL] [Abstract][Full Text] [Related]
23. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.
Alnajar H; Rosen L; Javidiparsijani S; Al-Ghamdi Y; Gattuso P
Acta Cytol; 2017; 61(2):140-144. PubMed ID: 28231581
[TBL] [Abstract][Full Text] [Related]
25. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
26. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
[TBL] [Abstract][Full Text] [Related]
27. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
29. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
30. Leptomeningeal metastasis: Clinical experience of 519 cases.
Hyun JW; Jeong IH; Joung A; Cho HJ; Kim SH; Kim HJ
Eur J Cancer; 2016 Mar; 56():107-114. PubMed ID: 26841095
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
32. Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.
Ju Y; Sun S; Wang J; Jiao S
J Cancer Res Ther; 2016 Oct; 12(Supplement):126-129. PubMed ID: 27721269
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of leptomeningeal carcinomatosis from gastric cancer].
Okuda T; Kataoka K; Kato A
Gan To Kagaku Ryoho; 2009 Apr; 36(4):599-603. PubMed ID: 19381031
[TBL] [Abstract][Full Text] [Related]
35. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
36. Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients.
Ha B; Chung SY; Kim YJ; Gwak HS; Chang JH; Lee SH; Park IH; Lee KS; Lee S; Kim TH; Kim DY; Kang SG; Suh CO
Cancer Res Treat; 2017 Jul; 49(3):748-758. PubMed ID: 27809457
[TBL] [Abstract][Full Text] [Related]
37. Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa.
Comte A; Jdid W; Guilhaume MN; Kriegel I; Piperno-Neumann S; Dieras V; Dorval T; Pierga JY; Cottu PH; Mignot L; Bidard FC
J Neurooncol; 2013 Dec; 115(3):445-52. PubMed ID: 24043602
[TBL] [Abstract][Full Text] [Related]
38. Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
Martens J; Venuturumilli P; Corbets L; Bestul D
Acta Oncol; 2013 Jan; 52(1):175-8. PubMed ID: 22655969
[No Abstract] [Full Text] [Related]
39. Leptomeningeal metastasis from systemic cancer: Review and update on management.
Wang N; Bertalan MS; Brastianos PK
Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer.
Pluchart H; Jacquet E; Charlety D; Allenet B; Bedouch P; Mousseau M
Target Oncol; 2016 Oct; 11(5):687-691. PubMed ID: 27041112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
